What's New on the FDA Drugs Site
September 11, 2017
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- Drug Development in Pediatric Heart Failure: Extrapolation, Clinical Trial Design, and Endpoints Public Workshop Announcement
- FDA Drug Shortages
- Cefotetan Disodium Injection (Updated - Currently in Shortage)
- Imipenem and Cilastatin for Injection, USP (Updated - Currently in Shortage)
- Leucovorin Calcium Lyophilized Powder for Injection (Updated - Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine (Updated - Currently in Shortage)
- Methylprednisolone Sodium Succinate for Injection, USP (Updated - Currently in Shortage)
- Multi-Vitamin Infusion (Adult and Pediatric) (Updated - Currently in Shortage)
- Multi-Vitamin Infusion (Adult and Pediatric) (Updated - Discontinuation)
- Potassium Chloride Injection (Updated - Currently in Shortage)
- Potassium Phosphate Injection (Updated - Currently in Shortage)
- Rocuronium Bromide Injection (Updated - Currently in Shortage)
- Sodium Acetate Injection, USP (Updated - Currently in Shortage)
- Sodium Bicarbonate Injection, USP (Updated - Currently in Shortage)
- Montelukast Sodium Chewable Tablet (New - Discontinuation)
- La FDA recomienda separar las dosis de sulfonato de poliestireno sódico (Kayexalate) para reducir los niveles de potasio, de las de todo otro medicamento oral
- Manual of Policies and Procedures (MAPP) 4301.1 Rev. 2 Center for Drug Evaluation and Research Medical Policy Council (PDF - 244KB)
- National Drug Code Directory (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
No hay comentarios:
Publicar un comentario